The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Successful generation of patient derived xenografts and patient derived 3D cultures as preclinical models for breast cancer.
 
Verena Imke Isabel Kiver
No Relationships to Disclose
 
Guido Gambara
No Relationships to Disclose
 
Karolin Fuchs
No Relationships to Disclose
 
Bernadette Brzezicha
No Relationships to Disclose
 
Caroline Schweiger
No Relationships to Disclose
 
Philipp Jurmeister
No Relationships to Disclose
 
Olga Gorea
No Relationships to Disclose
 
Susen Burock
No Relationships to Disclose
 
Cornelia Liedtke
Honoraria - Amgen; AstraZeneca; Celgene; Eisai; Gedeon Richter; Genomic Health; GlaxoSmithKline; Novartis; Pierre Fabre; Puma Biotechnology; Roche; Teva
Consulting or Advisory Role - Genomic Health; Novartis; Pierre Fabre; Roche; Teva
Speakers' Bureau - Genomic Health
Research Funding - Boehringer Ingelheim; Eisai; Novartis; Roche
Travel, Accommodations, Expenses - Celgene; Daiichi Sankyo; PharmaMar; Roche; Teva
 
Maria Margarete Karsten
No Relationships to Disclose
 
Nikola Bangemann
No Relationships to Disclose
 
Jens U. Blohmer
No Relationships to Disclose
 
Carsten Denkert
Stock and Other Ownership Interests - Sividon Diagnostics
Honoraria - Amgen; Novartis; Pfizer; Roche; Teva
Consulting or Advisory Role - Amgen; MSD Oncology
Patents, Royalties, Other Intellectual Property - Predictive gene expression signature for therapy response; VMScope digital pathology software
 
Christian RA Regenbrecht
Stock and Other Ownership Interests - Cellular Phenomics and Oncology
 
Jens Hoffmann
Employment - EPO Berlin GmbH
Stock and Other Ownership Interests - Cellular Phenomics and Oncology; EPO Berlin GmbH
 
Ulrich Keilholz
Honoraria - AstraZeneca; Bristol-Myers Squibb; Glycotope GmbH; Merck KGaA; MSD Oncology; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD Oncology; pfizer
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Glycotope GmbH; Merck Serono; MSD Oncology; Novartis
Research Funding - Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Merck Serono; MSD Oncology